Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market was valued at USD 0.45 Billion in 2022 and is projected to reach USD 1.12 Billion by 2030, growing at a CAGR of 12.3% from 2024 to 2030.
From 2018 to 2022, the market for Fluralaner API grew due to key factors such as advancements in pharmaceutical formulations, government approvals for veterinary drugs, and increased research into the efficacy of these treatments. Demand surged particularly in North America and Europe, where pet adoption rates soared, coupled with the growing concern for animal healthcare. The veterinary sector, focusing on more sustainable and efficient solutions for parasites, significantly boosted the demand for Fluralaner-based products during this period.
The forecast from 2023 to 2033 looks even more promising, with a projected increase in market demand driven by various factors, such as the rising awareness of the importance of regular parasite control, the continuous improvement in veterinary drug research, and the expansion of the global pet population. The development of new formulations, which include long-acting treatments for flea and tick infestations, is expected to propel the market further. Moreover, emerging economies are expected to witness a surge in demand for these veterinary drugs due to growing pet populations and improving access to veterinary care.
Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market
Get an In-Depth Research Analysis of the Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size And Forecast [2025-2032]
The Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient (API) Market has witnessed a steady growth trajectory between 2018 and 2022. Fluralaner, a veterinary drug primarily used for treating parasitic infections in pets, particularly fleas and ticks, has seen increasing demand due to the rise in pet ownership and the growing prevalence of zoonotic diseases globally. With its powerful long-lasting effects, Fluralaner has become a go-to solution for veterinarians worldwide. This market, valued at millions of dollars in 2022, reflects the increasing focus on pet health and the rise of animal wellness industries.
Nissan Chemical
HIKAL Ltd.
HuBei Masteam Bio-tech
Jiangsu Rivocean
Shaanxi Dideu Group
Zhejiang Gihi Chemicals
Taizhou Crene Biotechnology
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market
Oral Drug
External Drug
Based on Types the Market is categorized into Below types that held the largest Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient market share In 2023.
Purity ≥98%
Purity <98%
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Analysis
1. Introduction of the Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, By Type
6. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, By Application
7. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/